BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30446315)

  • 21. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
    McKenzie JT; Guarnaschelli JN; Vagal AS; Warnick RE; Breneman JC
    J Neurooncol; 2013 Jul; 113(3):403-9. PubMed ID: 23589034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
    Combs SE; Ahmadi R; Schulz-Ertner D; Thilmann C; Debus J
    J Neurooncol; 2005 Feb; 71(3):319-23. PubMed ID: 15735924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypofractionated reirradiation for recurrent malignant glioma.
    Henke G; Paulsen F; Steinbach JP; Ganswindt U; Isijanov H; Kortmann RD; Bamberg M; Belka C
    Strahlenther Onkol; 2009 Feb; 185(2):113-9. PubMed ID: 19240998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-irradiation in the Brain: Primary Gliomas.
    Ho ALK; Jena R
    Clin Oncol (R Coll Radiol); 2018 Feb; 30(2):124-136. PubMed ID: 29295736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
    Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
    Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma.
    Kessel KA; Hesse J; Straube C; Zimmer C; Schmidt-Graf F; Schlegel J; Meyer B; Combs SE
    PLoS One; 2017; 12(7):e0180457. PubMed ID: 28678889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse.
    Antoni D; Jastaniah Z; Haoming QC; Gaultier C; Ahle G; Couchot J; Atlani D; Schott R; Clavier JB; Srour R; Chaussemy D; Noël G
    Cancer Radiother; 2016 Jun; 20(4):282-91. PubMed ID: 27318555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.
    Agas RAF; Yu KKL; Sogono PG; Co LBA; Jacinto JCKM; Bacorro WR; Mejia MBA
    J Glob Oncol; 2019 Feb; 5():1-14. PubMed ID: 30735433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment*.
    Yonezawa H; Ohno M; Igaki H; Miyakita Y; Takahashi M; Tamura Y; Shima S; Matsushita Y; Ichimura K; Narita Y
    Jpn J Clin Oncol; 2021 Jul; 51(7):1028-1035. PubMed ID: 33959771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
    Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.
    Shi W; Blomain ES; Siglin J; Palmer JD; Dan T; Wang Y; Werner-Wasik M; Glass J; Kim L; Bar Ad V; Bhamidipati D; Evans JJ; Judy K; Farrell CJ; Andrews DW
    J Neurooncol; 2018 Mar; 137(1):171-177. PubMed ID: 29235052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity and efficacy of re-irradiation of high-grade glioma in a phase I dose- and volume escalation trial.
    Møller S; Munck Af Rosenschöld P; Costa J; Law I; Poulsen HS; Engelholm SA; Engelholm S
    Radiother Oncol; 2017 Nov; 125(2):223-227. PubMed ID: 29054380
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Fleischmann DF; Unterrainer M; Bartenstein P; Belka C; Albert NL; Niyazi M
    J Neurooncol; 2017 Apr; 132(2):277-286. PubMed ID: 28102485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial.
    Maranzano E; Anselmo P; Casale M; Trippa F; Carletti S; Principi M; Loreti F; Italiani M; Caserta C; Giorgi C
    Tumori; 2011; 97(1):56-61. PubMed ID: 21528665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
    Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study.
    Siker ML; Firat SY; Mueller W; Krouwer H; Schultz CJ
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):765-72. PubMed ID: 21236600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital Biomarkers.
    Straube C; Kessel KA; Zimmer C; Schmidt-Graf F; Schlegel J; Gempt J; Meyer B; Combs SE
    Curr Treat Options Oncol; 2019 Jul; 20(9):71. PubMed ID: 31324990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status and recent advances in reirradiation of glioblastoma.
    Minniti G; Niyazi M; Alongi F; Navarria P; Belka C
    Radiat Oncol; 2021 Feb; 16(1):36. PubMed ID: 33602305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.
    Song A; Andrews DW; Werner-Wasik M; Kim L; Glass J; Bar-Ad V; Evans JJ; Farrell CJ; Judy KD; Daskalakis C; Zhan T; Shi W
    Radiother Oncol; 2019 Mar; 132():135-141. PubMed ID: 30825962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.